← Back to Search

Breast Implant

MemoryGel Breast Implants for Breast Reconstruction (Athena Trial)

N/A
Waitlist Available
Research Sponsored by Mentor Worldwide, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A candidate for revision surgery in women at least 18 years old with surgically absent breast tissue
A candidate for primary breast reconstruction in women at least 18 years old with surgically absent breast tissue
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 year
Awards & highlights

Athena Trial Summary

This trial will study the safety and effectiveness of larger Mentor MemoryGel breast implants.

Who is the study for?
This trial is for women at least 18 years old needing primary or revision breast reconstruction due to absent breast tissue. Participants must agree to follow-up visits, return the implant if removed, and have a suitable body mass index (BMI) and chest width. Exclusions include pregnancy, uncontrolled diabetes, recent nursing of a child, conditions affecting wound healing or posing surgical risks, untreated breast cancer, certain autoimmune diseases or immune deficiencies.Check my eligibility
What is being tested?
The safety and effectiveness of Mentor MemoryGel Larger Size Ultra High Profile Breast Implants are being tested in women undergoing primary or revision breast reconstruction. The study focuses on how well these larger implants work and monitors any complications that may arise post-surgery.See study design
What are the potential side effects?
Potential side effects from using these implants can include pain at the surgery site, infection around the implant, changes in nipple sensation, scar tissue formation causing stiffness (capsular contracture), possible rupture of the implant with leakage of silicone gel material.

Athena Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman over 18 needing surgery to revise a previous breast operation.
Select...
I am a woman over 18 needing breast reconstruction due to surgery.

Athena Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Any Reoperation
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Baker III, IV Capsular Contracture
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Explantation with or without replacement
+1 more

Athena Trial Design

2Treatment groups
Experimental Treatment
Group I: Revision Breast ReconstructionExperimental Treatment1 Intervention
participants who meet the requirements for revision breast reconstruction (have had previous silicone or saline breast implants) and have been implanted with Mentor Larger Size MemoryGel Ultra High Profile Breast implants
Group II: Primary Breast ReconstructionExperimental Treatment1 Intervention
Participants who meet the requirements for primary breast reconstruction (have not had previous silicone or saline breast implants, not including tissue expanders) and have been implanted with Mentor Larger Size MemoryGel Ultra High Profile Breast implants

Find a Location

Who is running the clinical trial?

Mentor Worldwide, LLCLead Sponsor
24 Previous Clinical Trials
52,538 Total Patients Enrolled
10 Trials studying Breast Reconstruction
46,813 Patients Enrolled for Breast Reconstruction
John Canady, M.D.Study DirectorMentor Worldwide, LLC
3 Previous Clinical Trials
45,337 Total Patients Enrolled
3 Trials studying Breast Reconstruction
45,337 Patients Enrolled for Breast Reconstruction
Medical DirectorStudy DirectorMentor Worldwide, LLC
2,777 Previous Clinical Trials
8,063,464 Total Patients Enrolled
2 Trials studying Breast Reconstruction
3,828 Patients Enrolled for Breast Reconstruction

Media Library

Mentor Larger Size MemoryGel Ultra High Profile Breast Implant (Breast Implant) Clinical Trial Eligibility Overview. Trial Name: NCT02724371 — N/A
Breast Reconstruction Research Study Groups: Primary Breast Reconstruction, Revision Breast Reconstruction
Breast Reconstruction Clinical Trial 2023: Mentor Larger Size MemoryGel Ultra High Profile Breast Implant Highlights & Side Effects. Trial Name: NCT02724371 — N/A
Mentor Larger Size MemoryGel Ultra High Profile Breast Implant (Breast Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02724371 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment require any additional participants?

"Evidence hosted on clinicaltrials.gov reveals that, as of this moment, the study is not open for recruitment. The trial was initially announced on April 1st 2016 and had its last update recorded at November 28th 2022. However, there are two additional trials actively seeking participants currently."

Answered by AI

In which locations is this clinical trial in effect?

"This trial is presently being conducted across 30 sites, comprising of Philadelphia, Scottsdale, Stanford and other nearby locations. Therefore, it would be opportune to pick a location near you in order to decrease travel needs if you become part of the study."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
Arizona
Other
California
How old are they?
18 - 65
What site did they apply to?
The Mount Sinai Medical Center
Mayo Clinic Arizona - Scottsdale/Phoenix (MCSB)
Susan E Downey MD, Inc
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Hopefully this trail will help me with my current issue with my breast. I currently have implants that were implanted 10/18/2022 and they were done badly. Hoping for a revision. I had no complications first time.. got through it very well.
PatientReceived 1 prior treatment
~149 spots leftby Jan 2029